CoChat

Phase I study of eptifibatide in patients with sickle cell anaemia

Lee, Sheritha P., Ataga, Kenneth I., Zayed, Mohamed, Manganello, Jeanne M., Orringer, Eugene P., Phillips, David R., Parise, Leslie V. · 2007 · British Journal of Haematology
Cited by 50

The DOI matches its Crossref record.

Abstract

Summary: The α IIb β 3 antagonist eptifibatide is an effective treatment for patients with acute coronary syndromes (ACS). Platelet reactivity and CD40 ligand (CD40L) may play a role in the pathophysiology of sickle cell anaemia (SCA) similar to that in ACS, suggesting that inhibition of platelet aggregation and CD40L release by eptifibatide may benefit patients with SCA. Following eptifibatide infusion, safety and pharmacodynamic data were obtained from four SCA patients in their non‐crisis, steady states. Eptifibatide was well tolerated, with no adverse changes in the haematological, biochemical or coagulation parameters studied. Eptifibatide did not increase plasma levels of platelet factor 4 or beta‐thromboglobulin, P‐selectin exposure or platelet:leucocyte aggregate formation. Moreover, decreases in platelet aggregation and soluble CD40L (sCD40L) levels achieved in SCA patients were comparable to those observed in the treatment of ACS. Finally, indicators of inflammation, macrophage inflammatory protein‐1 α , tumour necrosis factor‐ α and myoglobin were reduced following eptifibatide infusion, while vasodilation correlatives, matrix metalloproteinases (MMP‐2 and MMP‐9) and leptin were increased. Based on these phase I results, eptifibatide may benefit SCA patients by inhibiting platelet aggregation, decreasing sCD40L levels and favourably altering plasma levels of inflammatory mediators.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2007.06787.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 50

Metadata

Authors
Lee, S. P., Ataga, K. I., Zayed, M., Manganello, J. M., Orringer, E. P., Phillips, D. R., & Parise, L. V.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2007-10-08
Volume
139
Issue
4
Pages
612-620
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2002874515
Cited by
50
References
0
FWCI
1.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phase I study of eptifibatide in patients with sickle cell anaemia. https://app.cochat.ai/papers/10.1111/j.1365-2141.2007.06787.x
The paper
Lee, S. P., Ataga, K. I., Zayed, M., Manganello, J. M., Orringer, E. P., Phillips, D. R., & Parise, L. V. (2007). Phase I study of eptifibatide in patients with sickle cell anaemia. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2007.06787.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.